Skip to main content
Top
Gepubliceerd in: Bijblijven 3/2013

01-03-2013 | Artikelen

Overzicht van risicofactoren voor het ontstaan van mammacarcinoom

Auteurs: Prof. dr. G.H. de Bock, dr. C.M. Kets, prof. dr. C.J. van Asperen

Gepubliceerd in: Bijblijven | Uitgave 3/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Er zijn verschillende factoren die het risico van mammacarcinoom beïnvloeden. Deze factoren kunnen het risico van mammacarcinoom bij een individuele patiënt sterk beïnvloeden. Indien van toepassing, kan op basis van deze factoren het beleid/advies aan de patiënt worden gegeven. In het algemeen is het toenemen van de leeftijd de belangrijkste risicofactor; om die reden start in Nederland het bevolkingsonderzoek vanaf de leeftijd van 50 jaar. Er is daarnaast reden om standaard intensievere screening aan te bieden aan vrouwen met in de voorgeschiedenis mammacarcinoom, vrouwen die voor het 40e jaar thoraxbestraling hebben gehad, een erfelijke aanleg voor mammacarcinoom hebben, of op basis van de familieanamnese een twee of meer keer zo hoge kans op mammacarcinoom hebben.
Literatuur
2.
go back to reference McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. Brit Med J 2000;321:624-8.PubMedCrossRef McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. Brit Med J 2000;321:624-8.PubMedCrossRef
3.
go back to reference Dumitrescu RG, Cotarla I. Understanding breast cancer risk – where do we stand in 2005? J Cell Mol Med 2005;9:208-21.PubMedCrossRef Dumitrescu RG, Cotarla I. Understanding breast cancer risk – where do we stand in 2005? J Cell Mol Med 2005;9:208-21.PubMedCrossRef
4.
go back to reference Ruis MWG, Verhoef S, Rookus MA, Pruntel R, Hout AH van der, Hogervorst FBL, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MGEM, Hoogerbrugge N, Asperen CJ van, Gomez Garcia EB, Meijers-Heijboer H, Kate LP ten, Menko FH, Veer LJ van ’t. TP53 germline mutation testing in 180 families suspected of LieFraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 2010;47:421-8.CrossRef Ruis MWG, Verhoef S, Rookus MA, Pruntel R, Hout AH van der, Hogervorst FBL, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MGEM, Hoogerbrugge N, Asperen CJ van, Gomez Garcia EB, Meijers-Heijboer H, Kate LP ten, Menko FH, Veer LJ van ’t. TP53 germline mutation testing in 180 families suspected of LieFraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 2010;47:421-8.CrossRef
5.
go back to reference Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012;18:400-7.PubMedCrossRef Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012;18:400-7.PubMedCrossRef
6.
go back to reference Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-72.PubMed Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961-72.PubMed
7.
go back to reference Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-99.CrossRef Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358:1389-99.CrossRef
8.
go back to reference Morrow M. Identification of the woman at risk for breast cancer: problem solved? Recent Results Cancer Res 1999;151:85-95.PubMedCrossRef Morrow M. Identification of the woman at risk for breast cancer: problem solved? Recent Results Cancer Res 1999;151:85-95.PubMedCrossRef
9.
go back to reference Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. Review. J Natl Cancer Inst 2010;102:1224-37.PubMedCrossRef Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. Review. J Natl Cancer Inst 2010;102:1224-37.PubMedCrossRef
11.
go back to reference Bruin ML de, Sparidans J, Veer MB van’t, Noordijk EM, Louwman MW, Zijlstra JM, et al. Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27:4239-46.PubMedCrossRef Bruin ML de, Sparidans J, Veer MB van’t, Noordijk EM, Louwman MW, Zijlstra JM, et al. Breast cancer risk in female survivors of Hodgkin’s lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27:4239-46.PubMedCrossRef
12.
go back to reference Leeuwen FE van, Klokman WJ, Stovall M, Dahler EC, Veer MB van’t, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease. J Natl Cancer Inst 2003;95:971-80.PubMedCrossRef Leeuwen FE van, Klokman WJ, Stovall M, Dahler EC, Veer MB van’t, Noordijk EM, et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin’s disease. J Natl Cancer Inst 2003;95:971-80.PubMedCrossRef
13.
go back to reference Aleman BM, Belt-Dusebout AW van den, Klokman WJ, Veer MB van’t, Bartelink H, Leeuwen FE van. Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 2003;21:3431-9.PubMedCrossRef Aleman BM, Belt-Dusebout AW van den, Klokman WJ, Veer MB van’t, Bartelink H, Leeuwen FE van. Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol 2003;21:3431-9.PubMedCrossRef
14.
go back to reference Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update 2010;16:631-50.PubMedCrossRef Cibula D, Gompel A, Mueck AO, La Vecchia C, Hannaford PC, Skouby SO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update 2010;16:631-50.PubMedCrossRef
15.
go back to reference Salhab M, Al Sarakbi W, Mokbel K. In vitro fertilization and breast cancer risk: a review. Int J Fertil Womens Med 2005;50:259-66.PubMed Salhab M, Al Sarakbi W, Mokbel K. In vitro fertilization and breast cancer risk: a review. Int J Fertil Womens Med 2005;50:259-66.PubMed
16.
go back to reference Dor J, Lerner-Geva L, Rabinovici J, Chetrit A, Levran D, Lunenfeld B, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324-7.PubMedCrossRef Dor J, Lerner-Geva L, Rabinovici J, Chetrit A, Levran D, Lunenfeld B, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324-7.PubMedCrossRef
17.
go back to reference Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, et al. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 2010;124:13-26.PubMedCrossRef Zreik TG, Mazloom A, Chen Y, Vannucci M, Pinnix CC, Fulton S, et al. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 2010;124:13-26.PubMedCrossRef
18.
go back to reference Brennan SF, Cantwell MM, Cardwell CR, Velentzis LS, Woodside JV. Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr 2010;91:1294-302.PubMedCrossRef Brennan SF, Cantwell MM, Cardwell CR, Velentzis LS, Woodside JV. Dietary patterns and breast cancer risk: a systematic review and meta-analysis. Am J Clin Nutr 2010;91:1294-302.PubMedCrossRef
19.
go back to reference Key J, Hodgson S, Omar RZ, Jensen TK, Thompson SG, Boobis AR, et al. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 2006;17:759-70.PubMedCrossRef Key J, Hodgson S, Omar RZ, Jensen TK, Thompson SG, Boobis AR, et al. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 2006;17:759-70.PubMedCrossRef
20.
go back to reference Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J National Cancer Inst 2010;102:1422-31.CrossRef Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, et al. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women’s health initiative observational study. J National Cancer Inst 2010;102:1422-31.CrossRef
21.
go back to reference Patterson RE, Cadmus LA, Emond JA, Pierce JP. Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 2010;66:5-15.PubMedCrossRef Patterson RE, Cadmus LA, Emond JA, Pierce JP. Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 2010;66:5-15.PubMedCrossRef
22.
go back to reference Bernstein L. Identifying population-based approaches to lower breast cancer risk. Oncogene 2009;27:S3-S8.CrossRef Bernstein L. Identifying population-based approaches to lower breast cancer risk. Oncogene 2009;27:S3-S8.CrossRef
25.
go back to reference Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan TH, Andrulis IL, Hopper JL, Goodwin PJ, O’Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore AS, West DW, John EM. Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. Breast Cancer Res Treat 2009;117:167-76.PubMedCrossRef Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan TH, Andrulis IL, Hopper JL, Goodwin PJ, O’Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, Whittemore AS, West DW, John EM. Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. Breast Cancer Res Treat 2009;117:167-76.PubMedCrossRef
26.
go back to reference McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.PubMedCrossRef McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1159-69.PubMedCrossRef
27.
go back to reference Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C, Ouweland A van den, Menke-Pluymers MB, Bartels CC, Kriege M, Geel AN van, Burger CW, Eggermont AM, Meijers-Heijboer H, Klijn JG. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 2007; 43:867-76.PubMedCrossRef Brekelmans CT, Tilanus-Linthorst MM, Seynaeve C, Ouweland A van den, Menke-Pluymers MB, Bartels CC, Kriege M, Geel AN van, Burger CW, Eggermont AM, Meijers-Heijboer H, Klijn JG. Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. Eur J Cancer 2007; 43:867-76.PubMedCrossRef
28.
go back to reference Bock GH de, Hage JA van der, Putter H, Bonnema J, Bartelink H, Velde CJ van de. Isolated locoregional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer 2006;42:351-6.PubMedCrossRef Bock GH de, Hage JA van der, Putter H, Bonnema J, Bartelink H, Velde CJ van de. Isolated locoregional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies. Eur J Cancer 2006;42:351-6.PubMedCrossRef
32.
go back to reference Heijnsdijk EA, Warner E, Gilbert FJ, Tilanus-Linthorst MM, Evans G, Causer PA, Eeles RA, Kaas R, Draisma G, Ramsay EA, Warren RM, Hill KA, Hoogerbrugge N, Wasser MN, Bergers E, Oosterwijk JC, Hooning MJ, Rutgers EJ, Klijn JG, Plewes DB, Leach MO, Koning HJ de. Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 2012;21:1458-68.PubMedCrossRef Heijnsdijk EA, Warner E, Gilbert FJ, Tilanus-Linthorst MM, Evans G, Causer PA, Eeles RA, Kaas R, Draisma G, Ramsay EA, Warren RM, Hill KA, Hoogerbrugge N, Wasser MN, Bergers E, Oosterwijk JC, Hooning MJ, Rutgers EJ, Klijn JG, Plewes DB, Leach MO, Koning HJ de. Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined. Cancer Epidemiol Biomarkers Prev 2012;21:1458-68.PubMedCrossRef
33.
go back to reference FH01 collaborative teams. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 2010;11:1127-34.CrossRef FH01 collaborative teams. Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 2010;11:1127-34.CrossRef
Metagegevens
Titel
Overzicht van risicofactoren voor het ontstaan van mammacarcinoom
Auteurs
Prof. dr. G.H. de Bock
dr. C.M. Kets
prof. dr. C.J. van Asperen
Publicatiedatum
01-03-2013
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Bijblijven / Uitgave 3/2013
Print ISSN: 0168-9428
Elektronisch ISSN: 1876-4916
DOI
https://doi.org/10.1007/s12414-013-0032-z

Andere artikelen Uitgave 3/2013

Bijblijven 3/2013 Naar de uitgave